Brain natriuretic peptide as a marker of left ventricular hypertrophy in patients with aortic stenosis

Journal of Heart Valve Disease

Volumn 17, Issue 6, 2008, Pages 598-605

  Orlowska Baranowska, Ewa ^a   Baranowski, Rafal ^a   Greszata, Lidia ^a   Stepinska, Janina ^a  

^a INSTITUTE OF CARDIOLOGY   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE;

AGE; AORTA VALVE STENOSIS; ARTICLE; BLOOD; DIASTOLE; ECHOGRAPHY; FEMALE; HEART LEFT VENTRICLE HYPERTROPHY; HEART STROKE VOLUME; HUMAN; MALE; MIDDLE AGED;

AGE FACTORS; AORTIC VALVE STENOSIS; BIOLOGICAL MARKERS; DIASTOLE; FEMALE; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; STROKE VOLUME;

EID: 59649105790     PISSN: 09668519     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Boomsma F, van den Meiracker AH. Plasma A-and B-type natriuretic peptides: Physiology, methodology and clinical use. Cardiovasc Res 2001;51:442-449 (Pubitemid 32718592)
2. Ikeda T, Matsuda K, Itoh H, et al. Plasma levels of brain and atrial natriuretic peptides elevate in proportion to left ventricular end-systolic wall stress in patients with aortic stenosis. Am Heart J 1997;133:307-314
3. Koglin J, Pehlivanli S, Schwaiblmair M, Vogeser M, Cremer P, Scheidt W. Role of brain natriuretic peptide in risk stratification of patients with congestive heart failure. J Am Coll Cardiol 2001;38:1934-1941 (Pubitemid 33116567)
4. Maeda K, Tsuyamoto T, Wada A, Hisanaga T, Kinishita M. Plasma brain natriuretic peptide as a biochemical marker of high level ventricular enddiastolic pressure in patients with symptomatic left ventricular dysfunction. Am Heart J 1998;135:825-832 (Pubitemid 28237306)
5. Doggrell S. Brain natriuretic peptide: Disease marker or more in cardiovascular medicine? Drugs Today 2001;37:463-476
6. Lim P, Monin JL, Monchi M, et al. Predictors of outcome in patients with severe aortic stenosis and normal left ventricular function: Role of B-type natriuretic peptide. Eur Heart J 2004;25:1972-1973
7. Kupari M, Turto H, Lommi J. Diagnosing heart failure in aortic valve stenosis. J Intern Med 2004;256:381-387 (Pubitemid 39434374)
8. Qi W, Mathisen P, Kjekshus J, et al. Natriuretic peptides in patients with aortic stenosis. Am Heart J 2001;142:725-732 (Pubitemid 32900502)
9. Kupari M, Turto H, Lommi J, Makijarvi M, Parikka H. Transcardiac gradient of N-terminal B-type natriuretic peptide in aortic valve stenosis. Eur J Heart Fail 2005;7:809-814 (Pubitemid 41125898)
10. Prasad N, Bridges A, Lang C, et al. Brain natriuretic peptide concentrations in patients with aortic stenosis. Am Heart J 1997;133:477-479 (Pubitemid 27188474)
11. Golbasy Z, Ucar O, Yuksel AG, Gulel O, Aydogdu S, Ulusoy V. Plasma brain natriuretic peptide levels in patients with rheumatic heart disease. Eur J Heart Fail 2004;6:757-760 (Pubitemid 39470231)
12. Bergler-Klein J, Klaar U, Heger M, et al. Natriuretic peptides predict symptom-free survival and postoperative outcome in severe aortic stenosis. Circulation 2004;109:2302-2308 (Pubitemid 38678520)
13. Bergler-Klein J, Mundigler G, Pibarot P, et al. B-type natriuretic peptide in low-flow, low-gradient aortic stenosis: Relationship to hemodynamics and clinical outcome. Results from the Multicenter Truly or Pseudo-Severe Aortic Stenosis (TOPAS) study. Circulation 2007;15:2848-2855 (Pubitemid 46869672)
14. Maron B, Tholakanahalli V, Zenovich A, et al. Usefulness of B-type natriuretic peptide assay in the assessment of symptomatic state in hypertrophic cardiomyopathy. Circulation 2004;109:984-989 (Pubitemid 38282851)
15. Fukuda N, Shinohara H, Sakabe K, Nada T, Tamura Y. Plasma levels of brain natriuretic peptide in various forms of obstruction to the left ventricular outflow tract. J Heart Valve Dis 2003;12:333-340 (Pubitemid 36675647)
16. Mizuno Y, Yoshimura M, Harada E, et al. Plasma levels of A-and B-type natriuretic peptides in patients with hypertrophic cardiomyopathy or idiopathic dilated cardiomyopathy. Am J Cardiol 2000;86:1036-1040
17. Paulus W. Natriuretic peptides to probe haemodynamic overload in hypertrophic cardiomyopathy. Eur Heart J 2001;15:1249-1250
18. Libby P, Bonow RO, Mann DL, Zipes DP. Braunwald's Heart Disease. A Textbook of Cardiovascular Medicine, 8th edition, Elsevier Saunders, Philadelphia, 2008
19. Bonow RO, Carabello B, deLeon AC, et al. ACC/AHA Guidelines for the management of patients with valvular heart disease: A report of the American College of Cardiology/American Heart Association task force on practice guidelines (committee on management of patients with valvular heart disease). J Am Coll Cardiol 1998;32:1486-1588
20. Bonow RO, Carabello B, Kanu C, et al. ACC/AHA 2006 Guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease). Developed in collaboration with the Society of Cardiovascular Anesthesiologists: Endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. Circulation 2006:114:e84-e231 (Pubitemid 44268973)
21. Vahanian A, Baumagartner H, Bax J, et al. Guidelines on the management of valvular heart disease. The task force of the management of valvular heart disease of the European Society of Cardiology. Eur Heart J 2007;28:230-268 (Pubitemid 46276943)
22. Murakami Y, Shimada T, Inoue S, et al. New insight into the mechanism of the elevation of plasma brain natriuretic polypeptide levels in patients with left ventricular hypertrophy. Can J Cardiol 2002;18:1294-1300 (Pubitemid 36215780)
23. Kohno M, Horio T, Yokokawa K, et al. Brain natriuretic peptide as a marker for hypertensive left ventricular hypertrophy: Changes during 1 year antihypertensive therapy with angiotensin-converting enzyme inhibitor. Am J Med 1995;98:257-265
24. Loke I, Squire I, Davies J, Ng L. Reference range for natriuretic peptides for diagnostic use are dependent on age, gender and heart rate. Eur J Heart Fail 2003;3:599-606 (Pubitemid 38043963)
25. Vanderheyden M, Goethals M, Verstreken S, et al. Wall stress modulates brain natriuretic peptide production in pressure overload cardiomyopathy. J Am Coll Cardiol 2004;44:2349-2354 (Pubitemid 39647609)
26. Hirata Y, Matsumoto A, Aoyagi T, et al. Measurement of plasma brain natriuretic peptide level as a guide for cardiac overload. Cardiovasc Res 2001;51:585-591 (Pubitemid 32718607)
27. Yasumoto K, Takata M, Ueno H, Tomita S, Tomoda F, Inoue H. Relation of plasma brain and atrial natriuretic peptides to left ventricular geometric patterns in essential hypertension. Am J Hypertens 1999;12:921-924 (Pubitemid 29469947)
28. Nakamura M, Tanaka F, Yonezwa S, Satou K, Nagano M, Hiramori K. The limited value of plasma B-type natriuretic peptide for screening for left ventricular hypertrophy among hypertensive patients. Am J Hypertens 2003;16:1025-1029 (Pubitemid 37500797)
29. Gerber I, Stewart R, Legget M, et al. Increased plasma natriuretic peptide levels reflect symptom onset in aortic stenosis. Circulation 2003;107:1884-1890 (Pubitemid 36444129)
30. Weber M, Arnold R, Rau M, et al. Relation of N-terminal pro B-type natriuretic peptide to progression of aortic valve disease. Eur Heart J 2005;26:1023-1030 (Pubitemid 40695033)
31. Talwar S, Downie P, Squire I, Davies J, Barnett D, Ng L. Plasma N-terminal pro BNP and cardiotrophin-1 are elevated in aortic stenosis. Eur J Heart Fail 2001;3:15-19 (Pubitemid 32127104)
32. Weber M, Arnold R, Rau M, et al. Relation of N-terminal pro-B-type natriuretic peptide to severity of valvular aortic stenosis. Am J Cardiol 2004;94:740-745 (Pubitemid 39221490)
33. Hosoda K, Nakao K, Mukoyama M, et al. Expression of brain natriuretic peptide gene in human heart. Hypertension 1991;17:1152-1156
34. Ogino K, Ogura K, Kinugawa T, et al. Neurohumoral profiles in patients with hypertrophic cardiomyopathy: Differences to hypertensive left ventricular hypertrophy. Circ J 2004;68:444-450 (Pubitemid 38657533)